HUMAN CYTOCHROME P450 INDUCTION AND INHIBITION POTENTIAL OF CLEVIDIPINE AND ITS PRIMARY METABOLITE H152/81

THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · Drug Metabolism and Disposition · 2003 · 784 citations

Medicine, Pharmacokinetics, Pharmacology +17

Current Progress on Esterases: From Molecular Structure to Function

Tetsuo Satoh, Palmer Taylor, William Bosron et al. · Drug Metabolism and Disposition · 2002 · 293 citations

Life Sciences, Biochemistry, Pharmacology +17

Substrate-Dependent Modulation of CYP3A4 Catalytic Activity: Analysis of 27 Test Compounds with Four Fluorometric Substrates

David M. Stresser, Andrew P. Blanchard, Stephanie D. Turner et al. · Drug Metabolism and Disposition · 2000 · 276 citations

Medicine, Pharmacokinetics, Pharmacology +17

Induction of Human CYP2C9 by Rifampicin, Hyperforin, and Phenobarbital Is Mediated by the Pregnane X Receptor

Yuping Chen, Stephen Ferguson, Masahiko Negishi et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 222 citations

Medicine, Pharmacology, Biochemical Pharmacology +12

Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions

Miki Katoh, Masatoshi Nakajima, Noriaki Shimada et al. · European Journal of Clinical Pharmacology · 2000 · 157 citations

Medicine, Pharmacokinetics, Pharmacology +16